---
title: Transcript Markers from Urinary Extracellular Vesicles for Predicting Risk
  Reclassification of Prostate Cancer Patients on Active Surveillance
date: '2024-07-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39001515/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240713181721&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Serum prostate-specific antigen (PSA), its derivatives, and magnetic
  resonance tomography (MRI) lack sufficient specificity and sensitivity for the prediction
  of risk reclassification of prostate cancer (PCa) patients on active surveillance
  (AS). We investigated selected transcripts in urinary extracellular vesicles (uEV)
  from PCa patients on AS to predict PCa risk reclassification (defined by ISUP 1
  with PSA > 10 ng/mL or ISUP 2-5 with any PSA level) in control biopsy. Before the
  ...
disable_comments: true
---
Serum prostate-specific antigen (PSA), its derivatives, and magnetic resonance tomography (MRI) lack sufficient specificity and sensitivity for the prediction of risk reclassification of prostate cancer (PCa) patients on active surveillance (AS). We investigated selected transcripts in urinary extracellular vesicles (uEV) from PCa patients on AS to predict PCa risk reclassification (defined by ISUP 1 with PSA > 10 ng/mL or ISUP 2-5 with any PSA level) in control biopsy. Before the ...